Narrative review / 2002
Oral creatine supplementation may offer neuroprotective benefits and potentially lower atherosclerotic disease risk, though human trials are needed.
This review examines the roles of creatine and creatine kinase in health and disease. Oral creatine supplementation improved clinical symptoms in patients with AGAT and GAMT deficiencies, though not in creatine transporter deficiency. Additionally, it showed neuroprotective effects in animal models of Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. The authors note creatine may also reduce plasma homocysteine production to potentially lower atherosclerotic risk, but these findings require confirmation and safety evaluations in human clinical studies.
- Study type
- Narrative review
- Who was studied
- Patients with inborn errors of metabolism and animal models
- What was measured
- Neurological outcomes, neuroprotection, and potential atherosclerotic risk reduction
THE PAPER
Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?
Wyss M, Schulze A. Neuroscience, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.